The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPLZL.L Regulatory News (PLZL)

  • There is currently no data for PLZL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Consent Solicitation Results

9 Sep 2022 09:00

RNS Number : 9198Y
Polyus Finance PLC
09 September 2022
 

9 September 2022

Polyus Finance Plc announces the results of the Consent Solicitation for 2028 Notes

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO, OR TO ANY PERSON LOCATED OR RESIDENT IN, ANY JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS ANNOUNCEMENT OR THE MEMORANDUM.

Polyus Finance Plc (the "Issuer") today formally announces that it has concluded its consent solicitation (the "Consent Solicitation") in relation to the outstanding U.S.$700,000,000 3.25% Guaranteed Notes due 2028 (the "2028 Notes") issued by the Issuer on the terms and subject to the conditions set forth in the Consent Solicitation Memorandum dated 20 July 2022 (the "Memorandum"). Capitalised terms used in this announcement but not defined herein have the meanings given to them in the Memorandum.

The Issuer thanks all Noteholders who have responded promptly and participated in the Consent Solicitation and notifies that the Requisite Consents from the Noteholders of the 2028 Notes were obtained before the Consent Deadline (08 September 2022 5:00 p.m. (London time)).

Consents were distributed in the following way from outstanding amount of the notes:

· 2028 Notes - 77.07%

Consequently, the amendment and waiver of certain terms of the Trust Deed, Paying Agency Agreement and Terms and Conditions of the 2028 Notes have been approved by the Written Resolutions.

As of the Effective Time, I2 Capital Trust Corporation Ltd will act as the new trustee in respect of the 2028 Notes.

The following table sets forth details of the 2028 Notes:

Description of the 2028 Notes

ISIN Code/

Common Code

(Regulation S Notes)

ISIN Code/

Common Code/

CUSIP Code

(Rule 144A Notes)

Outstanding Principal Amount

U.S.$700,000,000 3.25% Guaranteed Notes due 2028

XS2396900685

239690068

US73181LAB71

239725104

73181LAB7

U.S.$700,000,000

 

Forward-looking statements

This announcement may contain "forward-looking statements" concerning Polyus group. Generally, the words "will", "may", "should", "could", "would", "can", "continue", "opportunity", "believes", "expects", "intends", "anticipates", "estimates" or similar expressions identify forward-looking statements. The forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements. Forward-looking statements include statements relating to future capital expenditures and business and management strategies and the expansion and growth of Polyus group's operations. Many of these risks and uncertainties relate to factors that are beyond Polyus group's ability to control or estimate precisely and therefore undue reliance should not be placed on such statements which speak only as at the date of this announcement. The Issuer and/or any Polyus group company assumes no obligation in respect of, and does not intend to update, these forward-looking statements, except as required pursuant to applicable law.

DISCLAIMER

This announcement must be read in conjunction with the Memorandum. 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCGRGDCCSGDGDC
Date   Source Headline
7th Jun 20223:41 pmRNSEGM results
13th May 20226:00 pmRNSChanges in shareholder structure
13th May 20222:35 pmRNSUpdate on LSE listing
12th May 20221:08 pmRNSNominations to the interim Board of Directors
29th Apr 20225:25 pmRNSAnnual Review
25th Apr 20222:26 pmRNSUpdate on operational and financial results
14th Apr 20221:14 pmEQSPOLYUS PJSC: Notice of EGM
11th Apr 20224:05 pmRNSChanges in senior management
6th Apr 202212:31 pmRNSChanges in shareholder structure
4th Apr 202211:40 amRNSFitch withdraws Polyus Finance Plc credit rating
4th Apr 202211:30 amRNSFitch withdraws PJSC Polyus credit rating
1st Apr 20225:11 pmRNSS&P lowers and withdraws Polyus credit rating
31st Mar 20224:45 pmRNSMoody’s withdraws Polyus Finance Plc credit rating
31st Mar 20224:29 pmRNSMoody’s withdraws PJSC Polyus credit rating
30th Mar 20221:03 pmRNSRepayment of Eurobond due 28 March 2022
23rd Mar 20224:31 pmRNSCorporate Update
23rd Mar 20224:23 pmRNSDirector/PDMR Shareholding
14th Mar 202212:49 pmRNSFitch downgrades PJSC Polyus rating
11th Mar 202211:34 amRNSMoody’s downgrades PJSC Polyus rating
9th Mar 20223:43 pmRNSChanges to the Board of Directors
9th Mar 20222:26 pmRNSConference call cancellation - replacement
9th Mar 20221:14 pmRNSS&P downgrades PJSC Polyus rating
7th Mar 20227:00 amRNSMSCI ESG Rating downgrades PJSC Polyus rating
7th Mar 20227:00 amRNSFitch downgrades PJSC Polyus rating to ‘B’
4th Mar 20223:37 pmRNSPJSC Polyus reports acquisition of shares
2nd Mar 20224:36 pmRNSPrice Monitoring Extension
2nd Mar 20222:09 pmRNSDirector/PDMR Shareholding
1st Mar 20224:43 pmRNSSecond Price Monitoring Extn
1st Mar 20224:38 pmRNSPrice Monitoring Extension
1st Mar 20227:00 amRNSFinancial results for 4Q and full year 2021
28th Feb 202210:54 amRNSNotice of Results – replacement
25th Feb 20222:37 pmRNSNotice of financial results for 4Q and 2021
8th Feb 20227:00 amRNSTrading update for 4Q 2021 and full year 2021
31st Jan 20224:51 pmRNSAnnounces launch of a buyback programme
30th Dec 20212:29 pmRNSDirector/PDMR Shareholding
23rd Nov 20217:00 amRNSFinancial results for the third quarter of 2021
18th Nov 20219:59 amRNSESG ratings and rankings update
17th Nov 202111:45 amRNSNotice of 3Q 2021 financial results
28th Oct 20214:00 pmRNSDirector/PDMR Shareholding
28th Oct 20217:00 amRNSTrading update for the third quarter of 2021
22nd Oct 20214:38 pmRNSDirector/PDMR Shareholding
14th Oct 20214:18 pmRNSClosing of USD 700 million Eurobonds offering
14th Oct 20214:03 pmRNSClosing of USD 700 million Eurobonds offering
8th Oct 202111:40 amRNSExpert RA raises Polyus credit rating to ‘ruAAA’
8th Oct 20218:28 amRNSResults of the capped tender offer
8th Oct 20218:19 amRNSResults of the capped tender offer
7th Oct 20219:12 amRNSINDICATIVE RESULTS OF THE CAPPED TENDER OFFER
7th Oct 20219:02 amRNSINDICATIVE RESULTS OF THE CAPPED TENDER OFFER
30th Sep 20212:12 pmRNSEGM results
28th Sep 202112:29 pmRNSTender offer for notes due 2022, 2023 and 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.